1. Introduction {#sec1}
===============

Coagulation Factor V is a large 330-kD glycoprotein which consists of 2224 amino acid residues including a 28-residue leader peptide, which is structurally and functionally homologous to coagulation Factor VIII \[[@B1], [@B2]\]. The human Factor V gene (official name *F*5) maps to chromosome 1q23 and contains 25 exons (8). Factor V deficiency is a rare autosomal recessive disorder (incidence \< 1 in 1 million), characterized by low levels of antigen and activity \[[@B3]\]. At present, more than one hundred deficiency-causing mutations in the *F*5 locus have been described, and although most of them are private, a few are common, being found in several individuals of both European, Middle-Eastern and Asiatic descents. In the present study, we used for the first time DNA next-generation sequence (NGS) analysis to detect mutation pattern in the entire *F*5 locus of a 26-year-old Hispanic parturient with severe Factor V deficiency, as well as in her asymptomatic parents and newborn baby. The relationship between combinations of mutations and clinical phenotypes was evaluated.

2. Case Presentation {#sec2}
====================

The study protocol was approved by IRB at PSU Hershey Medical College. It was performed in adherence to the tenets of the declaration of Helsinki. Written informed consent was obtained from all participants. The investigated patient was 26-year-old Hispanic (born in Columbia, South America) parturient (G4P1) with several bleeding episodes before and during present pregnancy, multiple fresh frozen plasma (FFP) transfusions, and a history of three miscarriages in the past. The patient was previously diagnosed clinically to have severe Factor V deficiency on the basis of several previous bleeding episodes and laboratory studies demonstrating coagulopathy with moderate to severe decrease in Factor V activity. The remaining past medical history was unremarkable. The family history revealed that both biological parents had no history of bleeding or other coagulation symptoms and had reported normal Factor V activity. In addition, she has two siblings, apparently without any clinical signs of coagulation disorders. In the course of the current pregnancy the patient delivered the healthy male newborn, who has not displayed, at the time of this analysis, any signs of coagulation abnormalities, besides decreased (36%) level of Factor V. For the purpose of this investigation, we collected the samples of blood (proband and newborn son) and saliva (both biological parents and proband\'s husband) for DNA analysis ([Figure 1](#fig1){ref-type="fig"}).

3. Mutation Analysis {#sec3}
====================

Genomic DNA (gDNA) was extracted from venous EDTA-whole blood sample (proband) or cord blood (newborn child) employing membrane ultrafiltration method (FujiFilm Life Sciences distributed by Autogene, Holliston, MA, USA), according to the manufacturer recommendations. The saliva samples were collected from both parents and proband/s husband into Oragene container (DNA Genotek, Canada) and extracted according to the manufacturer recommendations. Subsequently two gDNA samples from the proband were submitted to Otogenetics Corporation (Norcross, GA, USA) for target capture and sequencing. Briefly, gDNA was subjected to agarose gel and optical density ratio tests to confirm the purity and concentration prior to Covaris (Covaris, Inc., Woburn, MA, USA) fragmentation. Fragmented gDNAs were tested for size distribution and concentration using an Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA) and Nanodrop (Thermo Fisher Scientific, Wilmington DE, USA). Illumina libraries were made from qualified fragmented gDNA using NEBNext reagents (New England Biolabs, Ipswich, MA, USA) and the resulting libraries were subjected to exome enrichment using custom probes targeting 75 kb target on chromosome 1 (169, 481, 192--169, 555, 469 by GRCh 37, Hg19). The resultant libraries were tested for enrichment by qPCR and for size distribution and concentration by an Agilent Bioanalyzer 2100. The samples were then sequenced on an Illumina HiSeq2000 (Illumina, San Diego, CA, USA) which generated paired-end reads of 90 or 100 nucleotides. Data was analyzed for data quality, exome coverage, and exome-wide SNP/InDel using the platform provided by DNAnexus (DNAnexus, Inc, Mountain View, CA, USA). The detected polymorphisms in the coding sequence of the *F*5 locus were subsequently verified using classical Sanger sequencing using exon primers described by van Wijk et al. \[[@B4]\]. This analysis was performed by direct DNA sequencing using ABI Prism 3100 genetic analyzer (Applied Biosystems, Foster City, CA, USA).

By NGS, we generated about 549 million bases of sequence as pair-end 90 or 100 nucleotide reads, 86% of which was able to align to human reference sequence. A total of 23% of these sequences mapped to the targeted region corresponding to 75 kb sequence of the *F*5 locus (NM_0001304.4), with 540-fold mean coverage ([Table 1](#tab1){ref-type="table"}). At this depth of coverage, more than 95% of the target bases were covered to pass quality control filtering based on the PHRED score threshold of calling variants (PHRED \> 30). Eighty high-confidence variants were annotated in the target region (3 nonsynonymous single-nucleotide variants and 2 synonymous single-nucleotide variants in the coding region of the target ([Table 2](#tab2){ref-type="table"}), as well as 75 single-nucleotide variants in the noncoding sequence of the target ([Table 3](#tab3){ref-type="table"}). The missense variants were located in the exon 3 (D107H), 10 (R513K), and 23 (R2102H) of the *F*5 locus ([Figure 1](#fig1){ref-type="fig"}), and the investigated patient was a homozygous carrier for all these variants. These variants were additionally confirmed by the Sanger sequencing and showed perfect match in two duplicate samples. The additional verification of the DNA samples from the proband\'s newborn son and our patient\'s biological parents performed using the Sanger sequencing revealed that all of them were heterozygous carriers for all 3 missense variants ([Figure 2](#fig2){ref-type="fig"}). No presence of these variants was shown in the husband of the patient (i.e., biological father of the newborn child).

4. Discussion {#sec4}
=============

The current study presents several novel findings: (i) it employs NGS approach for molecular diagnosis of FV deficiency, including sequencing of both translated and untranslated regions of *F*5 locus; (ii) it diagnoses the inherited FV deficiency in the S. American Caucasian family of Hispanic ethnicity; and (iii) it depicts detailed genetic evidence for multiple, coinherited mutations in the *F*5 locus which may be responsible for opposite phenotype characteristics (i.e., increasing and decreasing thrombosis process).

The results of the current study indicate that the investigated proband was a homozygotic carrier of three separate missense mutations in the coding sequence of *F*5. Surprisingly, however, only one of the 3 detected missense mutations (R2102H) was described previously (and called at that time, R2074H, based on different amino acid number order) by Schijver et al. (2002) in the context of the deficiency of the Factor V \[[@B5]\]. This substitution results in the replacement of an arginine (R) by a histidine (H) in amino acid position 2102 located in the C2-domain of Factor V and several lines of evidence reported previously support the notion that this sequence variant is causative for Factor V deficiency phenotype. Interestingly the remaining two detected missense mutations were reported to be associated mostly with either thrombosis \[[@B6]--[@B8]\] or increased risk of preterm delivery (D107H) \[[@B9]\]. It is noteworthy that two missense point mutations which were detected in the current proband were previously described in different populations (R2102H in Tunisian population and R513K in Thai, Chinese and Sub-Saharan populations). Although Factor V deficiency and its causative mutations were reported previously from European Caucasians, it is, to our knowledge, the first detailed description of causative mutation in *F*5 locus in a family from South America and/or Hispanic ethnicity.

In addition, we established that the investigated proband was a homozygous carrier for two synonymous single-nucleotide variants: A135A (rs6029) and S184S (rs6022) previously reported in the online SNP Medline database. There is no information about the potential phenotypic significance of these mutations. In addition to the previously described single-point mutations in the coding region of *F*5 gene, the analysis of the NGS data from the proband established a presence of additional 75 polymorphisms in the untranslated sequence of the *F*5 locus (3 in 5′-UTR part, 71 in the intronic part, and 1 in the 3′-UTR part of the gene) ([Table 3](#tab3){ref-type="table"}). Six of these variants represent newly discovered variants, not presented previously in the SNP Medline database. The types of detected variants include single-nucleotide variants (4 insertions and 4 deletions), as well as 3 additional short indels. The phenotypic significance of these polymorphisms for the Factor V function remains unknown.

The most recently (Oct 2012) accessed Human Genome Mutation database ([www.hgmd.org](http://www.hgmd.org)) lists 145 missense mutations in the *F*5 locus associated with altered function of Factor V. From this list, 94 mutations represent single-point mutations, from which approximately 80 have been strongly associated with Factor V deficiency. In this respect, the present study does not add new mutations to this list but confirms the fact of previously described coinheritance of several separate mutations in the *F*5 locus \[[@B10], [@B11]\], and more importantly provides an example of co-inheritance of *F*5 mutations with presumably opposite phenotypic coagulation characteristics. Similar situation (i.e., coinheritance of polymorphic variants from which one is associated with decreased Factor V activity and other with increased thrombosis) was described previously for much more frequent prothrombotic Leiden mutations, or more recently, promoter −426 G/A polymorphism \[[@B12], [@B13]\]. Our finding confirms that other prothrombotic mutations in the *F*5 gene locus may be independently inherited in one patient.

The present study exemplifies the use of NGS approach for detailed diagnosis of the specific clinical pathology and identification of causative mutations for rare genetic disorder. This approach has been recently advocated for both diagnosis and therapy \[[@B14]\]. The obtained genetic data for this cases were successfully used clinically for the peripartum anesthetic management of the previously described patient \[[@B15]\]. Comprehensive genetic analysis through NGS based approaches will increasingly be helpful in establishing the diagnosis of Factor V deficiency (or other genetic coagulation disorders) and thereby improve patient management.
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###### 

Summary of coverage for analyzed samples by next generation sequencing method.

  Sample                        Average target coverage   Total bases   Total reads   Mapped reads   Bottleneck score
  ----------------------------- ------------------------- ------------- ------------- -------------- ------------------
  Original proband DNA sample   547                       583,280,200   5,832,802     4,964,887      31.81
  Duplicate                     534                       549,426,400   5,494,264     4,720,781      32.81

###### 

Mutations observed in coding sequences (CDS) of *F*5 gene in the investigated proband and her blood relatives.

  Patient                                 Bleeding phenotype                FV activity (%)   Variants in CDS of *F*5 gene               Mature FV protein variants   SNPs (ID)
  --------------------------------------- --------------------------------- ----------------- ------------------------------------------ ---------------------------- -----------
  Female proband                          Epistaxis multiple miscarriages   0--4%             Homozygote for nonsynonymous variants:                                   
  169486641 G \> C                        2102 R/H (exon 23)                No dbSNP ID                                                                               
  169519112 C \> T                        513 R/K (exon 10)                 rs6020                                                                                    
  169541513 C \> G                        107 D/H (exon 3)                  rs6019                                                                                    
  Homozygote for synonymous variants:                                                                                                                                 
  169529973 C \> T                        135 A/A (exon 4)                  rs6029                                                                                    
  169529826 C \> A                        184 S/S (exon 4)                  rs6022                                                                                    
                                                                                                                                                                      
  Newborn son of proband                  No bleeding                       36%               Heterozygote for nonsynonymous variants:                                 
  169486641 G \> C                        2102 R/H (exon 23)                No dbSNP ID                                                                               
  169519112 C \> T                        513 R/K (exon 10)                 rs6020                                                                                    
  169541513 C \> G                        107 D/H (exon 3)                  rs6019                                                                                    
  Heterozygote for synonymous variants:                                                                                                                               
  169529973 C \> T                        135 A/A (exon 4)                  rs6029                                                                                    
  169529826 C \> A                        184 S/S (exon 4)                  rs6022                                                                                    
                                                                                                                                                                      
  Mother of proband                       No bleeding                       Reported normal   Heterozygote for nonsynonymous variants:                                 
  169486641 G \> C                        2102 R/H (exon 23)                No dbSNP ID                                                                               
  169519112 C \> T                        513 R/K (exon 10)                 rs6020                                                                                    
  169541513 C \> G                        107 D/H (exon 3)                  rs6019                                                                                    
  Heterozygote for synonymous variants:                                                                                                                               
  169529973 C \> T                        135 A/A (exon 4)                  rs6029                                                                                    
  169529826 C \> A                        184 S/S (exon 4)                  rs6022                                                                                    
                                                                                                                                                                      
  Father of proband                       No bleeding                       Reported normal   Heterozygote for nonsynonymous variants:                                 
  169486641 G \> C                        2102 R/H (exon 23)                No dbSNP ID                                                                               
  169519112 C \> T                        513 R/K (exon 10)                 rs6020                                                                                    
  169541513 C \> G                        107 D/H (exon 3)                  rs6019                                                                                    
  Heterozygote for synonymous variants:                                                                                                                               
  169529973 C \> T                        135 A/A (exon 4)                  rs6029                                                                                    
  169529826 C \> A                        184 S/S (exon 4)                  rs6022                                                                                    
                                                                                                                                                                      
  Proband\'s husband                      No bleeding                       Reported normal   No above CDS variants detected in *F*5     ---                          ---

###### 

Summary of observed variants in noncoding sequences of *F*5 gene in investigated proband.

  Type of variant      Type of carrier   Position-R   Position-L   Reference base   Variant base   SNPs (ID)
  -------------------- ----------------- ------------ ------------ ---------------- -------------- -----------------------
  Variants in 5′-UTR                                                                               
                                                                                                   
  SNP                  Hom               169556050    169556051    c                t              rs2269648
  SNP                  Hom               169556152    169556153    g                t              New variant
  INS                  Het               169556812    169556812                     a              rs58897818
                                                                                                   
  Intronic variants                                                                                
                                                                                                   
  SNP                  Hom               169486641    169486642    g                c              rs9332666
  SNP                  Hom               169490392    169490393    g                c              rs2420370
  SNP                  Hom               169491555    169491556    g                a              rs2420371
  SNP                  Hom               169496536    169496537    g                c              New variant
  SNP                  Hom               169498056    169498057    a                g              rs2420372
  SNP                  Hom               169516507    169516508    g                a              rs12046953
  SNP                  Hom               169517159    169517160    c                t              rs12026997
  SNP                  Hom               169517385    169517386    a                g              rs12044669
  SNP                  Hom               169517904    169517905    g                a              rs2420374
  SNP                  Hom               169518703    169518704    t                c              rs58875232
  DEL                  Het               169518885    169518886    a                               rs55717622
  SNP                  Hom               169519417    169519418    g                a              rs7537742
  SNP                  Hom               169519765    169519766    a                g              rs13306331
  SNP                  Hom               169520098    169520099    a                g              rs10800456
  SNP                  Hom               169521553    169521554    g                a              rs2213868
  SNP                  Hom               169521733    169521734    c                t              rs9332582
  SNP                  Hom               169523346    169523347    a                g              rs7555832
  SNP                  Hom               169523389    169523390    t                c              rs11577059
  SNP                  Het               169523395    169523396    a                t              New variant
  SNP                  Het               169523396    169523397    a                g              New variant
  DEL                  Hom               169523397    169523398    t                               rs116132528
  INS                  Het               169524860    169524860                     cac            New variant
  SNP                  Het               169524865    169524866    a                g              New variant
  SNP                  Hom               169525312    169525313    c                t              rs9332579
  INS                  Het               169525558    169525558                     ctctggc        rs16684
  SNP                  Het               169525680    169525681    c                a              rs115199761
  SNP                  Hom               169525766    169525767    t                c              rs2239853
  INS                  Hom               169526266    169526266                     a              rs9332577
  SNP                  Hom               169526300    169526301    c                t              rs4656688
  SNP                  Hom               169526367    169526368    a                g              rs4656689
  SNP                  Hom               169526425    169526426    g                t              rs4656188
  SNP                  Hom               169526601    169526602    g                c              rs1894697
  SNP                  Hom               169526646    169526647    a                g              rs1894698
  SNP                  Hom               169526950    169526951    c                g              rs1894699
  SNP                  Hom               169527226    169527227    a                g              rs1981491
  DEL                  Hom               169527470    169527471    a                               rs3835454
  SNP                  Hom               169528075    169528076    c                g              rs9332570
  INS                  Het               169528255    169528255                     aaa            rs58738850
  SNP                  Hom               169528580    169528581    c                t              rs6012
  SNP                  Hom               169528722    169528723    c                t              rs6427201
  SNP                  Hom               169528830    169528831    c                t              rs6427202
  SNP                  Hom               169529031    169529032    a                c              rs6427203
  SNP                  Hom               169529132    169529133    c                t              rs6699691
  SNP                  Hom               169529138    169529139    c                t              rs58931047
  SNP                  Hom               169530070    169530071    a                c              rs7545236
  SNP                  Hom               169530077    169530078    g                t              rs7523043
  SNP                  Hom               169530093    169530094    t                c              rs7534848
  SNP                  Hom               169530176    169530177    c                g              rs7522982
  INS                  Hom               169530532    169530532                     a              rs5778621; rs77192101
  SNP                  Hom               169530586    169530587    t                c              rs1894701
  SNP                  Hom               169531442    169531443    t                c              rs7540556
  SNP                  Hom               169531571    169531572    t                c              rs4656690
  SNP                  Hom               169533266    169533267    g                a              rs6678795
  SNP                  Hom               169533744    169533745    t                a              rs724509
  SNP                  Hom               169534028    169534029    t                c              rs724507
  SNP                  Hom               169534966    169534967    t                a              rs2040443
  SNP                  Hom               169535353    169535354    c                g              rs6685578
  SNP                  Hom               169536167    169536168    t                c              rs2213869
  SNP                  Hom               169536650    169536651    g                a              rs2187955
  DEL                  Het               169536796    169536798    tt               t              New variant
  SNP                  Hom               169537678    169537679    a                g              rs6670678
  SNP                  Hom               169538466    169538467    g                a              rs9287095
  SNP                  Hom               169538544    169538545    c                t              rs2298908
  SNP                  Hom               169538603    169538604    t                g              rs2298906
  SNP                  Hom               169539348    169539349    t                g              rs6663533
  SNP                  Hom               169543263    169543264    c                a              rs10800457
  SNP                  Hom               169545413    169545414    a                g              rs6677374
  SNP                  Hom               169549775    169549776    t                c              rs10753787
  INS                  Het               169551560    169551560                     a              rs56901113
  SNP                  Hom               169554058    169554059    c                g              rs3753305
                                                                                                   
  Variants in 3′-UTR                                                                               
                                                                                                   
  SNP                  Hom               169479974    169479975    c                t              rs970740

Hom: homozygote, Het: heterozygote, SNP: single-nucleotide polymorphism, Del: deletion, and Ins: insertion

[^1]: Academic Editors: S.-C. Chae, P. D. Cotter, A. Sazci, and C. Yapijakis
